Market Research Logo

Colombia Pharmaceuticals and Healthcare Report Q3 2015

118 Pages BMI Research May 13, 2015 SKU: BMI5556366

Colombia Pharmaceuticals and Healthcare Report Q3 2015

BMI View: The government's push for improvement to the Colombian healthcare sector, combined with thecountry's growing burden of chronic conditions and reliance on imported drugs will keep the healthcareand pharmaceutical markets on positive trajectories. However, the country's expanding counterfeit drugmarket along with government bailouts for local health insurance schemes will remain a risk in 2015.

Headline Expenditure Projections

Pharmaceuticals: COP8,643bn (USD4.3bn) in 2014 to COP9,109bn (USD3.5bn) in 2015; +5.4% inlocal currency terms. Forecast revised downward from Q215 due to historical data.

Healthcare: COP53,417bn (USD26.7bn) in 2014 to COP57,381bn (USD22.2bn) in 2015; +7.4% in localcurrency terms. Forecast revised downward upward from Q215 due to historical data.

Show Full Description


Show Table of Contents



Colombia Pharmaceuticals and Healthcare Report Q3 2015

BMI Research
May 13, 2015

Pricing & Delivery

Report with 3 quarterly updates
$1,295
Report with 3 quarterly updates - 3 User License
$1,945
Report with 3 quarterly updates - 5 User License
$2,500
Report with 3 quarterly updates - Departmental/Site License
$2,995
Global Site License Fulfilled by Publisher
$6,995

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.



CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.


Download CTA

Share this report